Breaking● Reported

Cardurion Pharmaceuticals Presents Phase 2 Results for Tovinontrine (CRD-750), a PDE9 Inhibitor, as a Novel Treatment for Heart Failure

Opened 11 Oct 2026 22:35 WIB · last update 11 Oct 2026 22:35 WIB · 1 sources

reported 11 Oct 22:35 · reported by: Business Insider — Markets

Market reaction

Linked assets at the first close after the story opened, against the close before. Timing, not proof of cause.

No linked market series, or no close yet after the story opened.

Who is covering it

Distinct sources by type; one outlet counts once.

News 1

What the updates added

New fact · 1

Story timeline

Sunday 11 Oct 2026

22:35

New fact Business Insider — Markets

first report

◆ official · ● news · 𝕏 X · ▶ video · ▲▼ market move · X posts: link and metadata only.